Normosol-R
Active substance: SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE
INJECTION, SOLUTION · SODIUM CHLORIDE 526 mg/100mL, SODIUM ACETATE ANHYDROUS 222 mg/100mL, SODIUM GLUCONATE 502 mg/100mL, POTASSIUM CHLORIDE 37 mg/100mL, MAGNESIUM CHLORIDE 30 mg/100mL
United StatesActive
Marketing holder: ICU Medical Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- SODIUM CHLORIDE · 526 mg/100mL
- SODIUM ACETATE ANHYDROUS · 222 mg/100mL
- SODIUM GLUCONATE · 502 mg/100mL
- POTASSIUM CHLORIDE · 37 mg/100mL
- MAGNESIUM CHLORIDE · 30 mg/100mL
Registration
- Registration number
- 0990-7967
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0990-7967 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0990-7967 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0990-7967 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 0990-7967 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 0990-7967 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 0990-7967 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 0990-7967 · Verified 2026-10-09 · open in source